Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • MEDIVIR AB News

    0,23 € 0,00% +0,00 €
    19.04.24 21:44:05 Gettex aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EFZT
    ISIN: SE0020181014
    US-Symbol: MVRBF
    Typ: Aktie

    MEDIVIR AB News

    19.08.22 - PLX
    Medivir Q2 Revenue SEK 500 Thousand vs. Estimate SEK 500 Thousand
    (PLX AI) – Medivir Q2 adjusted EBITDA SEK -21.5 million. • Q2 adjusted free cash flow SEK -17.6 million
    19.08.22 - PR Newswire
    MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022
    MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022 PR Newswire
    15.02.22 - PLX
    Medivir Q4 EPS SEK -0.44
    (PLX AI) – Medivir Q4 revenue SEK 13.9 million.
    04.11.21 - PR Newswire
    Birinapant clinical study initiated by IGM Biosciences
    Birinapant clinical study initiated by IGM Biosciences PR Newswire
    03.11.21 - PLX
    Medivir Q3 EPS SEK -0.26
    (PLX AI) – Medivir Q3 revenue SEK 800 thousand.
    25.10.21 - PLX
    Medivir Names Jens Lindberg New CEO
    (PLX AI) – Medivir appoints Jens Lindberg as Chief Executive Officer. • He joins from Sedana Medical where he has been VP Commercial and acting CEO • Will assume position within ...
    11.10.21 - PR Newswire
    Medivir to present at the ProHearings shared Capital Markets Day
    Medivir to present at the ProHearings shared Capital Markets Day PR Newswire
    16.09.21 - PLX
    Medivir Says MIV-818 Phase 1b Study Had Positive Results
    (PLX AI) – Medivir positive study results of MIV-818 in HCC dose escalation section of the phase 1b study. • The overall safety profile was in line with expectations for this type of drug ...
    19.08.21 - PLX
    Medivir Q2 EPS SEK -0.35
    (PLX AI) – Medivir Q2 revenue SEK 900 thousand.
    01.07.21 - PR Newswire
    Medivir appoints Malene Jensen as VP Clinical Development
    Medivir appoints Malene Jensen as VP Clinical Development PR Newswire
    01.06.21 - PR Newswire
    Medivir to present at the Redeye Growth Day
    Medivir to present at the Redeye Growth Day PR Newswire
    25.05.21 - PR Newswire
    Medivir to present at the ABGSC Life Science Summit
    Medivir to present at the ABGSC Life Science Summit PR Newswire
    25.05.21 - PR Newswire
    Medivir announces the design of its upcoming MIV-818 combination study
    Medivir announces the design of its upcoming MIV-818 combination study PR Newswire
    20.05.21 - PR Newswire
    Positive results from investigator-initiated phase II clinical study of remetinostat in patients with squamous cell carcinoma published
    Positive results from investigator-​initiated phase II clinical study of remetinostat in patients with squamous cell carcinoma published PR Newswire
    05.05.21 - PR Newswire
    Resolutions at the Annual General Meeting in Medivir on 5 May 2021
    Resolutions at the Annual General Meeting in Medivir on 5 May 2021 PR Newswire
    28.04.21 - PR Newswire
    Medivir AB - Interim Report January - March 2021
    Medivir AB - Interim Report January - March 2021 PR Newswire
    20.04.21 - PR Newswire
    Medivir to participate at the Kempen Life Sciences Conference
    Medivir to participate at the Kempen Life Sciences Conference PR Newswire
    19.04.21 - PR Newswire
    Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818
    Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818 PR Newswire
    06.04.21 - PR Newswire
    Medivir 2020 Annual Report published
    Medivir 2020 Annual Report published PR Newswire
    31.03.21 - PR Newswire
    Number of shares and votes in Medivir
    Number of shares and votes in Medivir PR Newswire

    Newssuche

    Videos

    newspaper
    18.04.24
    Technical Trading: Gold mit weiterem Potenzial
    Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »